Deletion mutant of pseudorabies virus and vaccine containing said virus
AssigneeCentraal Diegeneeskundig Instituut
InventorsAntonius J. M. Berns, Arnold L. J. Gielkens, Robertus J. M. Moormann
Life of this patent
Estimating the term…
Abstract
A thymidine kinase deficient live deletion mutant of pseudorabies virus is provided. The mutant, designated PRV783 was derived from the live deletion mutant strain 2.4N3A by deleting a 19 bp sequence from the BamHI fragment 11 of strain 2.4N3A into which had been inserted an EcoRI restriction site at a unique cleavage site in fragment 11 for the restriction endonuclease XhoI. The 19 bp deletion encompasses the inserted EcoRI site in fragment 11 of strain 2.4N3A. PRV783 is useful for preparing vaccine compositions to immunize susceptible animals against infection by pseudorabies virus.
Claims8
A thymidine kinase deficient live deletion mutant of a pseudorabies virus having a genome of about 160,000 bp, said genome comprising
- (a) two inverted repeats, each of which contains cleavage sites for restriction endonucleases BamHI and KonI, BamHI digestion of the genome yielding two pairs of restriction fragments derived from the sequence of the inverted repeats, a larger fragment of each pair being designated as BamHI restriction fragment 5;
- and KpnI digestion of the genome yielding two fragments, designated KpnI restriction fragment E and KpnI restriction fragment H, each of said KpnI fragments containing the distal end of one of the inverted repeats;
- (b) a unique sequence, U.sub.s, located between the inverted repeats, said unique sequence comprising a BamHI restriction fragment of about 7 kbp in length designated BamHI restriction fragment 7, said BamHI fragment 7 containing two cleavage sites for restriction endonucleases MluI, the first MluI site being located at about the 5' end of the fragment and the second MluI site being located about 2 kbp from the 5' end of the fragment and a cleavage site for BglII at about 5 kbp from the 5' end of the fragment, said first MluI site and said BglII site defining an MluI-BglII subfragment of BamHI fragment 7, and
- (c) a gene for thymidine kinase, the 3' portion of which being encoded by BamHI restriction fragment 11, said thymidine kinase deficient deletion mutant containing
- (i) a deletion of about 100 bp in a portion of an inverted repeat which is common to BamHI fragment 5 and either KpnI fragment E or KpnI fragment H;
- (ii) a deletion of about 2.4 kbp within the MluI-BglII subfragment of the BamHI fragment 7, said deletion causing the loss of the second MluI site from BamHI fragment 7;
- and
- (iii) a 19 bp deletion in the thymidine kinase gene which produces a thymidine kinase negative phenotype in the virus, said deletion being located within the BamHI fragment 11 coding for the 3' part of the thymidine kinase gene and encompassing an EcoRI restriction site inserted into the BamHI fragment 11 at the unique cleavage site for restriction endonuclease XhoI.
A vaccine for prevention of pseudorabies virus infection in susceptible animals comprising an immunogenic amount of the thymidine kinase deficient live deletion mutant of pseudorabies virus designated strain PRV783 together with a physiologically acceptable carrier.
A method of vaccinating susceptible animals against pseudorabies virus infection comprising administering to said animals an immunogenically effective amount of a vaccine comprising a thymidine kinase deficient live deletion mutant of pseudorabies virus designated strain PRV783 together with a physiologically acceptable carrier.
A thymidine kinase deficient live deletion mutant of a virulent pseudorabies virus having a genome of about 160,000 bp, said genome comprising
- (a) two inverted repeats, each of which contains cleavage sites for restriction endonucleases BamHI and KpnI, BamHI digestion of the genome yielding two pairs of restriction fragments derived from the sequence of the inverted repeats, a larger fragment of each pair being designated as BamHI restriction fragment 5;
- and KpnI digestion of the genome yielding two fragments, designated KpnI restriction fragment E and KpnI restriction fragment H, each of said KpnI fragments containing the distal end of one of the inverted repeats;
- (b) a unique sequence, U.sub.s, located between the inverted repeats, said unique sequence comprising a BamHI restriction fragment of about 7 kbp in length designated BamHI restriction fragment 7, said BamHI fragment 7 containing two cleavage sites for restriction endonucleases MluI, the first MluI site being located at about the 5' end of the fragment and the second MluI site being located about 2 kbp from the 5' end of the fragment and a cleavage site for BglII at about 5 kbp from the 5' end of the fragment, said first MluI site and said BglII site defining an MluI-BglII subfragment of BamHI fragment 7, and
- (c) a gene for thymidine kinase, the 3' portion of which being encoded by BamHI restriction fragment 11, said thymidine kinase deficient deletion mutant containing
- (i) a deletion of about 100 bp in a portion of an inverted repeat which is common to BamHI fragment 5 and either KpnI fragment E or KpnI fragment H;
- (ii) a deletion of about 2.4 kbp within the MluI-BglII subfragment of the BamHI fragment 7, said deletion causing the loss of the second MluI site from BamHI fragment 7;
- and
- (iii) a 19 bp deletion in the thymidine kinase gene which produces a thymidine kinase negative phenotype in the virus, said deletion being located within the BamHI fragment 11 coding for the 3' part of the thymidine kinase gene and encompassing an EcoRI restriction site inserted into the BamHI fragment 11 at the unique cleavage site for restriction endonuclease XhoI.
Dependencies are inferred from the claim text.